DeepMed Research

University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Hyaluronic Acid Gels for Lower Lid Retraction

Phase 4

Withdrawn

Conditions: Ectropion

Interventions: Procedure: Hyaluronic acid
Procedure: Saline

First Posted Date: 2013-04-24

Last Posted Date: 2014-12-03

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT01838252

Locations: 🇺🇸
Jules Stein Eye Institute, Los Angeles, California, United States

Eban II: Intervention for HIV Sero-Discordant Couples

Not Applicable

Conditions: Sexually Transmitted Diseases
Disease Transmission, Infectious
HIV
Safe Sex

Interventions: Behavioral: Risk Reduction

First Posted Date: 2013-04-11

Last Posted Date: 2016-02-10

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 400

Registration Number: NCT01829282

Locations: 🇺🇸
Tarzana Treatment Centers, Long Beach, California, United States
🇺🇸
AIDS Project Los Angeles, Los Angeles, California, United States
🇺🇸
HIV Education & Prevention Project of Alameda County, Oakland, California, United States

and more 5 locations

An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents

Not Applicable

Completed

Conditions: Substance Abuse
Traumatic Stress

Interventions: Behavioral: Trauma-focused Substance Abuse Intervention

First Posted Date: 2013-04-08

Last Posted Date: 2023-09-29

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 117

Registration Number: NCT01825694

Locations: 🇺🇸
Behavioral Health Services, Los Angeles, California, United States

Whey Protein Effects on Gycemic Control and Vascular Function

Phase 1

Withdrawn

Conditions: Blood Sugar (Glucose) Control
Blood Vessel (Vascular) Dysfunction

Interventions: Dietary Supplement: Control protein
Dietary Supplement: Whey protein powder

First Posted Date: 2013-03-19

Last Posted Date: 2023-10-02

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT01814358

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Field Administration of Stroke Therapy-Blood Pressure Lowering

Phase 2

Terminated

Conditions: Intracerebral Hemorrhage
Ischemic Stroke

Interventions: Drug: Glycerly Trinitrate

First Posted Date: 2013-03-14

Last Posted Date: 2020-10-29

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 4

Registration Number: NCT01811693

Locations: 🇺🇸
FAST-MAG Clinical Trial Coordinating Center, Los Angeles, California, United States
🇺🇸
Los Alamitos Medical Center, Los Alamitos, California, United States

Salivary Biomarkers for Sjögren's Syndrome Detection

Completed

Conditions: Sjögren's Syndrome

First Posted Date: 2013-03-08

Last Posted Date: 2019-04-19

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 420

Registration Number: NCT01807689

Locations: 🇺🇸
UCLA - School of Dentistry, Los Angeles, California, United States

How Bone is Made in Children Receiving Dialysis

Phase 4

Conditions: Bone Mineralization Defect

Interventions: Drug: Vitamin D2

First Posted Date: 2013-02-26

Last Posted Date: 2013-02-26

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 60

Registration Number: NCT01799317

Locations: 🇺🇸
Childrens Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Loma Linda University, Loma Linda, California, United States

Schema, Emotion, and Behavior Therapy for Children

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Individual Cognitive Behavioral Therapy
Behavioral: Standard Community Treatment

First Posted Date: 2013-02-05

Last Posted Date: 2018-09-07

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 70

Registration Number: NCT01784263

Locations: 🇺🇸
Jeffrey Wood, Los Angeles, California, United States

A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services

Phase 4

Completed

Conditions: HIV Prevention

Interventions: Drug: emtricitabine 200mg/tenofovir 300mg

First Posted Date: 2013-02-01

Last Posted Date: 2018-04-06

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 328

Registration Number: NCT01781806

Locations: 🇺🇸
L.A. Gay and Lesbian Center, Los Angeles, California, United States
🇺🇸
The OASIS Clinic, Los Angeles, California, United States

Hypothermia in Acute Stroke With Thrombolysis Imaging Evaluation of Revascularization

Phase 2

Terminated

Conditions: Acute Ischemic Stroke

Interventions: Other: IV t-PA and normothermia
Device: IV-tPA and hypothermia

First Posted Date: 2013-01-29

Last Posted Date: 2017-04-13

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 6

Registration Number: NCT01778855

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸
Intercoastal Medical Group, Sarasota, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy